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ABSTRACT
Background: Pseudomonas aeruginosa is an important pathogen frequently associated with nosocomial infections affecting 
mainly immunosuppressed patients. In Veterinary Medicine, infections caused by P. aeruginosa are becoming increasingly 
frequent; infections are related to intrinsic or acquired resistance mechanisms, which limit the choice of effective agents.
Case:  This study describes the case of a four-month-old male Pitt Bull dog treated at the Small Animal Internal Medicine 
service of the Veterinary Hospital at the Health and Rural Technology Center of Federal University of Campina Grande, 
Patos/Paraíba. The patient presented with apathy, inappetence, moderate dehydration, tachypnea, tachycardia, hyperther-
mia, pale mucosae, small lesions in the pelvic limbs, with edema and subsequent widespread petechiae. Treatment with 
intravenous fluid therapy using 0.9% NaCl with B-complex vitamins, and 20 mg/kg cephalexin every 12 h was established. 
The patient did not respond well to treatment, and died two days later. Necropsy was performed at the Veterinary Pathology 
sector of the Hospital and histopathological findings revealed focally extensive areas of necrosis associated to myriads 
of bacteria and mild mononuclear inflammatory infiltrates in the liver, heart and kidneys. Secretions and organ fragments 
were submitted to the Microbiology Laboratory of the same institution, which identified a systemic bacterial infection 
caused by P. aeruginosa. In vitro bacterial susceptibility to 15 different antimicrobials was assessed using the Bauer-Kirby 
disk diffusion test in Mueller Hinton agar. The agent exhibited multiple resistance to enrofloxacin, cephalexin, ceftiofur, 
gentamicin, imipenem, kanamycin, cephalothin, norfloxacin, amoxicillin, polymyxin B, ampicillin, tetracycline, and 
penicillin. It was sensitive to amikacin and neomycin only. Phenotypic detection was performed via disk approximation 
test (D-test) established by the Clinical and Laboratory Standard Institute (CLSI), which showed metallo-beta-lactamase 
(MBLs)-producing bacteria.
Discussion: Clinical-pathological and microbiological aspects confirmed a systemic infection by P. aeruginosa characterized 
by yellowish nodular lesions and occasional hemorrhage, associated with myriads of bacteria in the lumen of the vessels 
in multiple organs. The agent was probably disseminated hematogenously, and it is likely that the cutaneous lesions in the 
pelvic limbs were the entry point. Treatment using cephalexin proved to be inefficient for the animal of the present study, 
which may have been be due to the patient’s immunosuppression and the agent’s natural or acquired resistance to this drug; 
therefore, special care needs to be taken when using these antibiotics as a preventive measure against the dissemination of 
gram-negative (MBL)-producing P. aeruginosa. We can conclude that P. aeruginosa may cause systemic infection in dogs. 
Amikacin and neomycin are the most efficient antimicrobials for the in vitro elimination of the bacteria; however, other 
studies on the use of these drugs in vivo are needed. Considering the occurrence of resistance to multiple antimicrobials 
and the production of MBLs observed in this study, it is important to monitor P. aeruginosa through phenotypical and 
antimicrobial susceptibility tests to verify its level of resistance in diseases in Veterinary Medicine.
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INTRODUCTION
Pseudomonas aeruginosa is the most im-
portant strain of its species in Veterinary Medicine, 
although other species are also relevant in veterinary 
clinical practice, food hygiene, and water microbiol-
ogy. Pseudomonas aeruginosa are aerobic and non-
spore-forming bacteria, and present in the form of 
Gram-negative rods [6]. Infections caused by this agent 
are becoming increasingly frequent; they may occur 
acutely due to the production of toxins, and chronically 
owing to the formation of a thick biofilm.  Infections 
can also occur with both forms, production of toxins 
and biofilms, which combined can cause septicemia 
[14]. In Veterinary Medicine, P. aeruginosa is observed 
in otitis, cystitis, endometritis, dermatitis, abscesses, 
and pneumonia in domestic animals [17].
Treatment of infections by Pseudomonas 
aeruginosa is complicated due to the antimicrobial 
resistance related to intrinsic and acquired mecha-
nisms, limiting the choice of effective agents [5]. One 
of these mechanisms is the production of metallo-beta-
lactamases (MBLs), which are enzymes responsible for 
the beta-lactam-resistant phenotype. The emergence of 
innumerous MBL-producing strains in various regions 
of the world requires the development of fast, practi-
cal, and low-cost tests to assist in the microbiological 
routine [10]. The purpose of this study is to report a 
case of systemic infection caused by P. aeruginosa in 
a dog, demonstrating clinical, pathological and micro-
biological characteristics of this infection. 
CASE
A four-month-old male Pitt Bull dog was 
treated at the Small Animal Internal Medicine service 
of the Veterinary Hospital of the Health and Rural Tech-
nology Center at the Federal University of Campina 
Grande, Patos, Paraíba presented with muscle tremors, 
pain, and difficulty to walk. Clinical examination 
showed apathy, inappetence, moderate dehydration, 
tachypnea, tachycardia, hyperthermia, pale mucosae, 
and multiple petechiae throughout the body. The ani-
mal was hospitalized and received intravenous fluid 
therapy with 0.9 % NaCl with B-complex vitamins, 
and 20 mg/kg cephalexin every 12 h. The patient did 
not respond to treatment and died two days later. Nec-
ropsy showed a circular area of approximately 3 cm 
of diameter in the pelvic limb with an ulcerated center 
and elevated, irregular borders. Multifocal yellowish 
nodules varying from 0.2 to 1 cm of diameter were 
observed in the subcapsular surface of the kidneys, 
in the liver, left ventricular papillary muscles of the 
heart, and lungs. These nodules were surrounded by 
a reddish halo. Reddish areas were seen between the 
nodules, and also in the diaphragm, corticomedullary 
region of the kidneys, and in the serosa and mucosa 
of the bladder. The right pulmonary lobe was covered 
by a yellowish content.
Histopathological findings revealed focally 
extensive areas of necrosis associated with myriads of 
bacteria and mild mononuclear inflammatory infiltrate 
in the liver, heart and kidneys (Figure 1).
Organ fragments and secretions were sub-
mitted to the Microbiology Laboratory of the same 
institution, where the agent was identified.  Bacterial 
growth of macroscopical, smooth, round colonies with 
a fluorescent greenish color and a characteristic sweet 
scent was observed in MacConkey agar; microscopical 
Gram-negative rods were also visualized. Biochemical 
tests classified the isolated colonies as catalase- and 
oxidase-positive, reducers of nitrate to nitrite, and non-
sugar fermenting except for glucose; the agent was 
identified as P. aeruginosa (Figure 2 A) [12].
In vitro susceptibility was assessed in order to 
analyze the levels of bacterial resistance. The Bauer-
Kirby disk diffusion susceptibility test was used in 
Mueller Hinton agar to evaluate 15 different antimi-
crobials: amikacin, ampicillin, penicillin, amoxicillin, 
cephalexin, cephalothin, ceftiofur, gentamicin, neomy-
cin, kanamycin, norfloxacin, enrofloxacin, polymyxin 
B, imipenem and tetracycline. The agent exhibited 
multiple resistance to enrofloxacin, cephalexin, ceft-
iofur, gentamicin, imipenem, kanamycin, cephalotin, 
norfloxacin, amoxicillin, polimyxin B, ampicillin, 
tetracycline, and penicillin. It was sensitive to amikacin 
and neomycin only.
The disk approximation phenotypic test recom-
mended by the Clinical and Laboratory Standard Insti-
tute (CLSI) was used to verify the production of MBL. 
A suspension of P. aeruginosa was diluted to reach the 
McFarland standard no. 0.5 and inoculated on the sur-
face of a 4 mm-high Mueller Hinton agar plate. Next, 
disks containing the antibiotics ceftazidime (30 µg) 
and imipenem (10 µg) were positioned in the plate next 
to a sterile disk of filter paper added with a chelating 
solution of EDTA (ethylenediaminetetraacetic acid). 
After a 20h incubation period at 35°C, the zone of 
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inhibition of bacterial growth in the agar diffused with 
EDTA was distorted and amplified, confirming the 
production of MBLs (Figure 2 B).
DISCUSSION
Pseudomonas aeruginosa was diagnosed based 
on clinical and pathological aspects, and confirmed by 
microbiological tests. Systemic infection was charac-
terized by yellowish nodular lesions and occasional 
hemorrhage, associated with myriads of bacteria in 
the lumen of vessels in multiple organs. The dissemi-
nation of the agent was possibly hematogenous; the 
cutaneous lesions in the pelvic limbs were probably 
the entry point for the systemic infection. P. aeruginosa 
is considered environmental; disseminated in waters, 
humid soils, and vegetable surfaces; it may occasion-
ally cause infections in animals [7,16].
The clinical signs observed may be unspecific; 
however, the presence of hyperthermia and dissemi-
nated petechiae are characteristic clinical presentations 
of septicemia, which are usually associated with the 
opportunistic behavior of the microorganism and de-
creased immunity of the animal [11,16].  
Cephalexin is a first generation cephalosporin, 
considered to be active against Gram-positive bacteria 
and some Gram-negative aerobic bacteria [4]. In the 
present study, cephalexin did not prove to be effective; 
great bacterial resistance was observed, and therefore 
cephalexin is not a drug of choice in the treatment of 
systemic infections caused by P. aeruginosa. Similar 
results were found in a study of 18 samples of Pseu-
domonas aeruginosa, which presented elevated rates 
of resistance to cephalexin (99%) and cefotaxime 
(75.6%) in the in vitro susceptibility test [13]. The fact 
that the animal did not respond well to treatment with 
this antibiotic may be related to immunosuppression 
and natural or acquired resistance to these drugs by 
the infectious agent [16], which makes the clinical 
condition of the patient more severe and difficult to 
reverse [15]. Thereby, caution is recommended when 
using these antibiotics as a preventive measure against 
the dissemination of Gram-negative bacteria such as 
MBL-producing P. aeruginosa. In terms of antibiotic 
sensitivity, the most effective in vitro antimicrobials 
were amikacin and neomycin, in agreement with results 
obtained in other studies [3].
The multiple resistance rate observed in this 
case confirms observations of previous studies, which 
Figure 1. Liver. Focally extensive area of necrosis associated with 
myriads of intralesional and presence of adjacent mild mononuclear 
inflammatory [HE, obj 10x].
Figure 2. A- Humid, smooth, greenish colonies of Pseudomonas 
aeruginosa isolated from hepatic fragments in nutrient Agar. B- 
Pseudomonas aeruginosa presenting positive phenotypic test for 
metallo-beta-lactamase production. The test shows distortion and 
enhancement of the zone of inhibition of bacterial growth in the 
area where the chelating agent (EDTA) has been diffused.
B
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indicate a progressive, gradual increase of antibiotic 
resistance in Veterinary Medicine in the past decades, 
complicating the control of several conditions [9].It is 
important to be aware of infections caused by MBL-
producing bacteria to motivate the preventive measures 
required. In Veterinary Medicine the studies about 
MBLs are still limited; however, in Human Medicine, 
MBLs play a crucial role in the antibiotic resistance 
mechanisms [1,2,8,18,10].
Therefore, we can conclude that P. aeruginosa 
can cause systemic infection in dogs. The antimicrobi-
als proven effective to eliminate the bacteria in vitro 
were amikacin and neomycin. However, in vivo studies 
about the use of these drugs are required. 
The agent must be identified by means of a 
microbiological culture followed by a bacterial sus-
ceptibility test before treatment is instituted.
Due to the elevated multiple-resistance and 
production of MBLs, it is important to monitor P. aeru-
ginosa through phenotypical tests to verify its level of 
resistance in the various conditions affecting animals.
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